Austiofen 20 mg Tablets for dogs

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Veiklioji medžiaga:

Carprofen

Prieinama:

Chanelle Pharmaceuticals Manufacturing Limited

ATC kodas:

QM01AE91

INN (Tarptautinis Pavadinimas):

Carprofen

Dozė:

20 mg/tablet

Vaisto forma:

Tablet

Recepto tipas:

POM: Prescription Only Medicine as defined in relevant national legislation

Farmakoterapinė grupė:

Dogs

Gydymo sritis:

carprofen

Terapinės indikacijos:

N.S.A.I.D.

Autorizacija statusas:

Authorised

Leidimo data:

2006-06-02

Prekės savybės

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Austiofen 20 mg Tablets for dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENT
Carprofen
20.0 mg/tablet
EXCIPIENTS
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
A plain round flat bevelled edge white tablet with a breakline on one
side. The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of inflammation and pain caused by musculo-skeletal
disorders and degenerative joint disease. As a follow
up to parenteral analgesia in the management of post-operative pain.
4.3 CONTRAINDICATIONS
Do not use in cats.
Do not use in pups less than 4 months of age
Do not use in case of hypersensitivity to active substance or to any
of the excipients.
Do not
use in dogs suffering from cardiac,
hepatic or renal
disease,
where there is a possibility of gastro-intestinal
ulceration or bleeding, or where there is evidence of a blood
dyscrasia.
Refer to section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Refer to sections 4.3 and 4.5
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_6_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_1_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_0_
_8_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use in aged dogs may involve additional
risk.
If such a use cannot
be avoided,
dogs may require careful
clinical
ma